Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma

导出原文传递

翻译打印收藏纠错

作者： Noble, Richard A. ^[1] ; Bell, Natalie ^[2] ; Blair, Helen ^[3] ; Sikka, Arti ^[4] ; Thomas, Huw ^[5] ; Phillips, Nicole ; Nakjang, Sirintra ; Miwa, Satomi ; Crossland, Rachel ; Rand, Vikki ; Televantou, Despina ; Long, Anna ; Keun, Hector C. ; Bacon, Chris M. ; Bomken, Simon ; Critchlow, Susan E. ; Wedge, Stephen R.

作者单位： Imperial Coll London, Div Canc, London, England ^[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Cellular Pathol, Newcastle Upon Tyne, Tyne & Wear, England ^[2] AstraZeneca, Cambridge, England ^[3] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England ^[4] Newcastle Univ, Northern Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England ^[5]

发布时间 2018-01-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Haematologica

2017年102卷7期

1247-1257页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma

Haematologica

相似文献

Haematologica

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Inhibition of monocarboxyate transporter 1 by AZD3965 as a novel therapeutic approach for diffuse large B-cell lymphoma and Burkitt lymphoma

Haematologica

相似文献

Haematologica

相关期刊

检索历史清除